サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1795228

女性ヘルスケアの世界市場

Women's Healthcare

出版日
ページ情報
英文 189 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.55円
女性ヘルスケアの世界市場
出版日: 2025年08月21日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

女性ヘルスケアの世界市場は2030年までに121億米ドルに達する見込み

2024年に97億米ドルと推定される女性ヘルスケアの世界市場は、分析期間2024-2030年にCAGR 3.8％で成長し、2030年には121億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるホルモン不妊アプリケーションは、CAGR 3.4%を記録し、分析期間終了時には31億米ドルに達すると予測されます。閉経後骨粗鬆症応用分野の成長率は、分析期間中CAGR 2.6％と推定されます。

米国市場は26億米ドルと推定、中国はCAGR6.8%で成長予測

米国の女性ヘルスケア市場は2024年に26億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 6.8%で推移し、2030年には24億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.5%と2.8%と予測されています。欧州では、ドイツがCAGR約2.1%で成長すると予測されています。

世界の女性ヘルスケア市場- 主要動向と促進要因のまとめ

なぜ女性ヘルスケアは、世界ヘルスにおける際立った優先分野として台頭しつつあるのか？

女性ヘルスケアは、広範なヘルスケア・エコシステムの中で専門領域として急速に進化しています。これは、女性にはさまざまなライフステージにわたって特有の生理的、ホルモン的、生殖的な健康ニーズがあるという認識の高まりを反映しています。男女を問わず一般的な治療を行うことが多かった従来のヘルスケアモデルとは異なり、現代医療では性別に特化した診断、治療、予防医療の重要性がますます認識されるようになっています。女性の健康が優先されるようになった背景には、臨床研究において女性の割合が低く、制度的に軽視されてきた歴史があり、それが女性患者の誤診や最適とは言えないケアにつながってきました。今日、政府、ヘルスケア提供者、世界的組織は、月経の健康、不妊、妊娠、更年期、乳がん、婦人科がん、骨粗しょう症、自己免疫疾患などに焦点を当てたサービスを調整することで、こうした格差に対処することをより重視しています。社会運動やアドボカシー活動により、子宮内膜症、産後うつ病、避妊具へのアクセスなどの問題が注目され、政策対応や資金配分の改善が促されています。さらに、世界の女性の高齢化により、心血管の健康、骨密度、ホルモン調節に関連する慢性疾患の管理に対する需要が高まっています。女性のヘルスケアのニーズは生殖医療にとどまらないことを認識することで、医療界は、あらゆる年齢や背景を持つ女性に対し、タイムリーで正確、かつジェンダーに配慮したケアを保証する、より包括的で公平なシステムを開発するための一歩を踏み出しつつあります。

技術革新は女性ヘルスケアにどのような革命をもたらしているのか？

テクノロジーは、女性ヘルスケアの状況を再構築し、ケアをより個別化し、アクセスしやすくし、データ駆動型にする上で、変革的な役割を果たしています。最もインパクトのある開発のひとつは、モバイルアプリ、ウェアラブルデバイス、テレヘルスプラットフォームなどのデジタルヘルスツールの普及であり、これによって女性は自宅にいながら月経周期の追跡、妊娠経過のモニター、避妊アドバイスへのアクセス、慢性疾患の管理ができるようになりました。排卵トラッカーやAIによる体外受精（IVF）プラットフォームを含む不妊治療技術は、女性に生殖のタイムラインをより自由にコントロールする力を与えています。診断技術も向上し、高度な画像診断や遺伝子検査によって、乳がんや卵巣がんなどの病気の早期発見が可能になりました。遠隔診察は、女性が移動、スティグマ、近くに専門医がいないことなどに関連した障壁に直面することが多い、農村部や十分なサービスを受けていない地域では特に重要となっています。さらに、電子カルテと予測分析は、臨床医が個々の患者のプロファイルに基づいて治療計画を調整するのに役立っており、ホルモン療法や妊産婦ケアのような分野での転帰を改善しています。新興企業やフェムテック企業は、女性特有のニーズに特化した非侵襲的診断、デジタル骨盤底筋トレーナー、メンタルヘルス・プラットフォームなどの革新的なソリューションを開発することで、主導権を握っています。これらのイノベーションは、臨床ケアを向上させるだけでなく、長年のタブーを打ち破り、健康へのエンパワーメント文化を促進することで、女性がかつてないほど簡単かつ自信を持って、自分の健康に積極的な役割を果たすことを可能にしています。

女性ヘルスケア市場に影響を与える社会的変化と政策改革とは？

社会的認識と政策改革は、女性ヘルスケア市場の方向性と勢いを形成する上で、ますます重要な役割を果たしています。世界中で、女性は質の高いヘルスケアへのより良いアクセス、臨床研究における平等な代表、健康の不平等に対するより強い保護を要求しており、より強固な社会的言説や立法措置につながっています。政府や保健機関は、妊産婦ケア、不妊治療、避妊、がん検診の適用範囲を拡大する政策を制定しており、多くの場合、より広範な男女平等やユニバーサル・ヘルスケアの枠組みのもとで行われています。月経の公平性をめぐる世界の話題は、生理用品を無料で提供し、月経にまつわる偏見をなくすための教育を行うよう、医療機関に促しています。さらに、産後うつ病や不安障害など、女性のメンタルヘルスの課題が可視化されつつあることで、より包括的で統合的なメンタルヘルスケアサービスへのシフトが促されています。保険業者も、より良い予防ケアと長期的なウェルネス・ソリューションに対する市場の要望を反映し、より包括的な女性の健康に関する給付を盛り込み始めています。多嚢胞性卵巣症候群（PCOS）、子宮筋腫、更年期障害など、慢性的でありながら過小診断されている疾患の影響を受けている人々の声は、メディアやアドボカシー・キャンペーンによって増幅され続けており、医療界は調査と教育に投資するよう促しています。このような社会的・規制的転換は、医療へのアクセスを改善するだけでなく、女性の健康をめぐる文化的な物語を再構築し、女性の医学的懸念は妥当であり、制度的支援に値するものであることを肯定しています。その結果、情報に精通し、関与し、力を持つ患者層が増え、ヘルスケア・システムが自分たちのニーズと歩調を合わせて進化することを期待するようになっています。

女性ヘルスケア市場の世界の成長と長期的な可能性の原動力は何か？

女性ヘルスケア市場の成長は、人口統計学的、技術的、経済的、社会政治的要因の合流によってもたらされ、これらの要因が一体となって、性別に特化したヘルスケアソリューションへの投資の重要性と緊急性を強調しています。主な促進要因のひとつは、世界の女性人口の増加と平均寿命の伸びであり、その結果、加齢、ホルモンの変化、慢性疾患管理に関連した長期的ケアに対する需要が高まっています。女性の経済的エンパワーメントと教育水準の向上も、予防医療と個別化された治療オプションを積極的に求める、より健康リテラシーの高い消費者層の形成に寄与しています。不妊診断から遠隔医療プラットフォームに至るまで、医療技術の利用可能性と価格の上昇は、特にヘルスケア・インフラが急速に改善しつつある新興国において、アクセスを拡大し、早期介入を可能にしています。ベンチャーキャピタルによるフェムテックや女性中心の健康新興企業への投資は、市場にイノベーションを吹き込み、歴史的に無視されてきた分野への対処を支援しています。これと並行して、多国籍製薬会社は、ホルモン療法から標的がん治療まで、女性に影響を与える症状に合わせた新しい治療薬を発売しています。規制当局もこれに対応し、女性特有の医薬品や医療機器の承認経路を合理化し、市場開拓をさらに加速させています。企業のウェルネス・プログラムや職場の健康への取り組みも、女性特有の健康上の課題を認識し、対処することで、より良い健康アウトカムと生産性を促進し始めています。このように相互に関連し合う原動力は、ヘルスケアにおける男女格差の解消に向けた持続的なコミットメントを反映したものであり、女性が長きにわたって注目され、研究され、医療が進歩することを確実にするものです。女性の健康増進が家族、地域社会、経済の幸福の基盤であるという認識の高まりに支えられ、女性ヘルスケア市場は世界の拡大を続けています。

セグメント

アプリケーション（ホルモン性不妊アプリケーション、閉経後骨粗鬆症アプリケーション、子宮内膜症アプリケーション、避妊アプリケーション、更年期アプリケーション、多嚢胞性卵巣症候群アプリケーション、その他アプリケーション）

調査対象企業の例

  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Ava Women
  • Besins Healthcare
  • Bonzun
  • Duchesnay
  • Flo Health
  • Lilly（Eli Lilly）
  • Mayne Pharma
  • Medicines360
  • Midi Health
  • Morgan Stanley Inclusive Lab
  • Natural Cycles
  • Organon
  • Pfizer
  • Pristyn Care
  • Roche
  • Ru Medical（Unpause）
  • Sanofi

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38401

Global Women's Healthcare Market to Reach US$12.1 Billion by 2030

The global market for Women's Healthcare estimated at US$9.7 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Hormonal Infertility Application, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Postmenopausal Osteoporosis Application segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 6.8% CAGR

The Women's Healthcare market in the U.S. is estimated at US$2.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Women’s Healthcare Market - Key Trends & Drivers Summarized

Why Is Women’s Healthcare Emerging as a Distinct and Prioritized Sector in Global Health?

Women’s healthcare is rapidly evolving as a specialized domain within the broader healthcare ecosystem, reflecting the growing awareness that women have unique physiological, hormonal, and reproductive health needs across different life stages. Unlike traditional healthcare models that often generalized treatments for both genders, modern medicine increasingly recognizes the importance of gender-specific diagnostics, treatments, and preventive care. The prioritization of women’s health stems from a history of underrepresentation in clinical research and systemic neglect, which has led to misdiagnoses and suboptimal care for female patients. Today, governments, healthcare providers, and global organizations are placing a stronger emphasis on addressing these disparities by tailoring services that focus on menstrual health, fertility, pregnancy, menopause, breast and gynecological cancers, osteoporosis, and autoimmune diseases, among others. Social movements and advocacy efforts have brought attention to issues like endometriosis, postpartum depression, and contraceptive access, prompting better policy responses and funding allocation. In addition, an aging female population worldwide is increasing demand for chronic disease management related to cardiovascular health, bone density, and hormone regulation. By recognizing that women’s healthcare needs extend far beyond reproductive care, the medical community is taking steps to develop a more comprehensive and equitable system that ensures timely, accurate, and gender-sensitive care for women of all ages and backgrounds.

How Are Technological Innovations Revolutionizing the Women’s Healthcare Landscape?

Technology is playing a transformative role in reshaping the women’s healthcare landscape, making care more personalized, accessible, and data-driven. One of the most impactful developments is the proliferation of digital health tools such as mobile apps, wearable devices, and telehealth platforms that enable women to track their menstrual cycles, monitor pregnancy progress, access contraception advice, and manage chronic conditions from the comfort of their homes. Fertility tech, including ovulation trackers and AI-assisted in vitro fertilization (IVF) platforms, is empowering women with more control over their reproductive timelines. Diagnostic technologies have also improved, enabling earlier detection of diseases such as breast and ovarian cancer through advanced imaging and genetic testing. Remote consultations have become especially important in rural and underserved areas, where women often face barriers related to mobility, stigma, or lack of nearby specialists. In addition, electronic health records and predictive analytics are helping clinicians tailor treatment plans based on individual patient profiles, improving outcomes in areas like hormonal therapy and prenatal care. Startups and femtech companies are leading the charge by developing innovative solutions such as non-invasive diagnostics, digital pelvic floor trainers, and mental health platforms that cater specifically to women’s unique needs. These innovations are not only enhancing clinical care but also breaking down longstanding taboos and promoting a culture of health empowerment, allowing women to take an active role in their well-being with unprecedented ease and confidence.

What Societal Shifts and Policy Changes Are Influencing the Women’s Healthcare Market?

Societal awareness and policy reforms are playing an increasingly important role in shaping the direction and momentum of the women’s healthcare market. Around the world, women are demanding better access to quality healthcare, equal representation in clinical research, and stronger protections against health inequities, leading to more robust public discourse and legislative action. Governments and health agencies are enacting policies to expand coverage for maternal care, fertility treatments, contraception, and cancer screenings, often under broader gender equality or universal healthcare frameworks. The global conversation around menstrual equity is prompting institutions to provide free sanitary products and education, helping dismantle the stigma that surrounds menstruation. Additionally, the rising visibility of women’s mental health challenges, including postpartum depression and anxiety disorders, is prompting a shift toward more inclusive and integrated mental healthcare services. Insurance providers are also beginning to include more comprehensive women’s health benefits, reflecting market demand for better preventive care and long-term wellness solutions. Media and advocacy campaigns continue to amplify the voices of those affected by chronic yet underdiagnosed conditions such as polycystic ovary syndrome (PCOS), fibroids, and perimenopause symptoms, prompting the medical community to invest in research and education. These societal and regulatory shifts are not only improving access to care but also reshaping cultural narratives around female health, affirming that women’s medical concerns are both valid and deserving of systemic support. The result is a more informed, engaged, and empowered patient base that expects healthcare systems to evolve in step with their needs.

What Is Driving the Global Growth and Long-Term Potential of the Women’s Healthcare Market?

The growth in the women’s healthcare market is driven by a confluence of demographic, technological, economic, and sociopolitical factors that together underscore the importance and urgency of investing in gender-specific health solutions. One of the primary drivers is the rising global female population coupled with increased life expectancy, which is resulting in higher demand for long-term care related to aging, hormonal changes, and chronic illness management. Economic empowerment and higher educational attainment among women are also contributing to a more health-literate consumer base that actively seeks preventive care and personalized treatment options. The increasing availability and affordability of health technologies, from fertility diagnostics to telemedicine platforms, are expanding access and enabling earlier interventions, particularly in emerging economies where healthcare infrastructure is improving rapidly. Venture capital investment in femtech and women-centric health startups is infusing the market with innovation and helping address historically neglected areas. In parallel, multinational pharmaceutical companies are launching new therapeutics tailored to conditions affecting women, from hormone therapies to targeted cancer treatments. Regulatory bodies are responding by streamlining approval pathways for female-specific drugs and devices, further accelerating market development. Corporate wellness programs and workplace health initiatives are also beginning to recognize and address women’s unique health challenges, fostering better health outcomes and productivity. These interconnected drivers reflect a sustained commitment to closing the gender gap in healthcare, ensuring that women receive the attention, research, and medical advancements long overdue. The trajectory of the women’s healthcare market points toward continued global expansion, supported by a growing awareness that empowering women’s health is foundational to the well-being of families, communities, and economies.

SCOPE OF STUDY:

The report analyzes the Women's Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Ava Women
  • Besins Healthcare
  • Bonzun
  • Duchesnay
  • Flo Health
  • Lilly (Eli Lilly)
  • Mayne Pharma
  • Medicines360
  • Midi Health
  • Morgan Stanley Inclusive Lab
  • Natural Cycles
  • Organon
  • Pfizer
  • Pristyn Care
  • Roche
  • Ru Medical (Unpause)
  • Sanofi

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Women's Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Gender-Specific Health Needs Throws the Spotlight on Women's Healthcare as a Global Priority
    • Shift Toward Preventive Care Models Spurs Demand for Early Diagnosis and Screening Services Across Female Health Conditions
    • Here's How Digital Health Platforms Are Expanding Access to Reproductive and Menstrual Health Management
    • Increased Focus on Maternal Health and Safe Childbirth Strengthens the Business Case for Integrated Prenatal Care Solutions
    • Investment in Fertility Services and Egg Freezing Expands the Addressable Market Opportunity in Reproductive Technologies
    • Aging Female Population and Menopause Management Drive Innovation in Hormone Therapy and Lifestyle Interventions
    • Rising Mental Health Awareness Among Women Fuels Demand for Gender-Sensitive Therapy and Support Programs
    • Here's How FemTech Startups Are Disrupting Traditional Care Models with Personalized, App-Based Solutions
    • Growth in Gynecological Oncology Screening and Treatment Accelerates Adoption of Advanced Diagnostics and Surgical Tools
    • Workplace Wellness Programs and Corporate Benefits Support Expansion of Holistic Women-Centered Care Offerings
    • Access to Contraceptive Options and Family Planning Services Sustains Progress in Reproductive Autonomy and Choice
    • Global Rise in Polycystic Ovary Syndrome (PCOS), Endometriosis, and Autoimmune Disorders Highlights Unmet Needs in Women's Health
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Women's Healthcare Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Women's Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hormonal Infertility Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hormonal Infertility Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hormonal Infertility Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Postmenopausal Osteoporosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Postmenopausal Osteoporosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Postmenopausal Osteoporosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Endometriosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Endometriosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Endometriosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Contraceptives Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Contraceptives Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Contraceptives Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Menopause Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Menopause Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Menopause Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Polycystic Ovary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Polycystic Ovary Syndrome Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Polycystic Ovary Syndrome Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: China 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Women's Healthcare by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: France Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: France 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 47: Germany Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Germany Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Germany 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Italy 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 53: UK Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: UK Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: UK 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 56: Spain Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Spain Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Spain 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 59: Russia Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Russia Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Russia 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Rest of Europe 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Women's Healthcare by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Asia-Pacific 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Asia-Pacific 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 71: Australia Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Australia Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Australia 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 74: India Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: India Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: India 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 77: South Korea Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: South Korea Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: South Korea 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Asia-Pacific Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Rest of Asia-Pacific 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Women's Healthcare by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Latin America 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 86: Latin America Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Latin America Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Latin America 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 89: Argentina Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Argentina Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Argentina 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 92: Brazil Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Brazil Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Brazil 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 95: Mexico Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Mexico Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Mexico 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 98: Rest of Latin America Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Latin America Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Latin America 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Women's Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Women's Healthcare by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Middle East 16-Year Perspective for Women's Healthcare by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 104: Middle East Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Middle East Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Middle East 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 107: Iran Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Iran Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Iran 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 110: Israel Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Israel Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Israel 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 113: Saudi Arabia Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Saudi Arabia Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Saudi Arabia 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 116: UAE Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UAE Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: UAE 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 119: Rest of Middle East Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Middle East Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Middle East 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Women's Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 122: Africa Recent Past, Current & Future Analysis for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Africa Historic Review for Women's Healthcare by Application - Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Africa 16-Year Perspective for Women's Healthcare by Application - Percentage Breakdown of Value Sales for Hormonal Infertility Application, Postmenopausal Osteoporosis Application, Endometriosis Application, Contraceptives Application, Menopause Application, Polycystic Ovary Syndrome Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION